The Celera Genomics Group, of Rockville, Md., appointed James Yee head of development.

NicOx SA, of Sophia Antipolis, France, appointed Jean-Luc Belingard to its board.

Northfield Laboratories Inc., of Evanston, Ill., appointed Sophia Twaddell vice president, corporate communications.

NuGEN Technologies Inc., of San Carlos, Calif., appointed Inder Verma to its scientific advisory board.

Organogenesis Inc., of Canton, Mass., appointed Gary Gillheeney executive vice president and chief operating officer.

Orthovita Inc., of Malvern, Pa., appointed David Fitzgerald to its board.

Pharming Group NV, of Leiden, the Netherlands, added John Pieters to its board of supervisory directors.

Replidyne Inc., of Louisville, Colo., added Donald Morrissey as vice president, corporate development; Burton Goodman as director, informatics and automation; Garry Dallmann as director, lead discovery; and Ian Critchley as director, microbiology.

Serologicals Corp., of Atlanta, added David Bellitt as vice president, global commercial operations.

YM BioSciences Inc., of Mississauga, appointed Vincent Salvatori executive vice president. Also, Niclas Stiernholm, executive vice president and chief scientific officer, left the company, although he is now part of its scientific advisory board.